Fulgent Genetics (FLGT) Competitors $21.77 +0.37 (+1.73%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$21.81 +0.04 (+0.18%) As of 08/22/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT vs. HTFL, VCYT, ADUS, LFST, CELC, PGNY, ARDT, PACS, NHC, and VRDNShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Heartflow (HTFL), Veracyte (VCYT), Addus HomeCare (ADUS), LifeStance Health Group (LFST), Celcuity (CELC), Progyny (PGNY), Ardent Health (ARDT), PACS Group (PACS), National HealthCare (NHC), and Viridian Therapeutics (VRDN). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. Its Competitors Heartflow Veracyte Addus HomeCare LifeStance Health Group Celcuity Progyny Ardent Health PACS Group National HealthCare Viridian Therapeutics Heartflow (NASDAQ:HTFL) and Fulgent Genetics (NASDAQ:FLGT) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, analyst recommendations, risk, media sentiment, earnings and dividends. Is HTFL or FLGT more profitable? Heartflow has a net margin of 0.00% compared to Fulgent Genetics' net margin of -16.83%. Heartflow's return on equity of 0.00% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets HeartflowN/A N/A N/A Fulgent Genetics -16.83%-2.26%-2.10% Which has stronger earnings and valuation, HTFL or FLGT? Heartflow has higher earnings, but lower revenue than Fulgent Genetics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeartflowN/AN/AN/AN/AN/AFulgent Genetics$303.22M2.20-$42.71M-$1.66-13.11 Do insiders & institutionals hold more shares of HTFL or FLGT? 48.1% of Fulgent Genetics shares are held by institutional investors. 31.8% of Fulgent Genetics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Do analysts prefer HTFL or FLGT? Fulgent Genetics has a consensus price target of $25.33, suggesting a potential upside of 16.37%. Given Fulgent Genetics' stronger consensus rating and higher possible upside, analysts clearly believe Fulgent Genetics is more favorable than Heartflow.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heartflow 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67 Does the media favor HTFL or FLGT? In the previous week, Heartflow had 1 more articles in the media than Fulgent Genetics. MarketBeat recorded 2 mentions for Heartflow and 1 mentions for Fulgent Genetics. Fulgent Genetics' average media sentiment score of 1.67 beat Heartflow's score of 0.51 indicating that Fulgent Genetics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Heartflow 0 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Fulgent Genetics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryFulgent Genetics beats Heartflow on 7 of the 11 factors compared between the two stocks. Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FLGT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$666.36M$2.15B$5.81B$9.76BDividend YieldN/AN/A4.39%4.06%P/E Ratio-13.1138.6631.3626.05Price / Sales2.2050.62387.8788.42Price / CashN/A53.5538.0259.36Price / Book0.606.709.536.60Net Income-$42.71M-$63.67M$3.26B$265.65M7 Day Performance2.40%4.61%2.14%2.00%1 Month Performance18.25%1.26%3.22%0.46%1 Year Performance-8.53%26.44%30.18%18.88% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics3.6776 of 5 stars$21.77+1.7%$25.33+16.4%-8.5%$666.36M$303.22M-13.111,313Positive NewsHTFLHeartflowN/A$29.97-3.8%N/AN/A$2.53BN/A0.00699VCYTVeracyte2.8347 of 5 stars$30.07-0.5%$40.90+36.0%-3.1%$2.38B$445.76M91.12790News CoveragePositive NewsADUSAddus HomeCare4.9216 of 5 stars$114.19-0.8%$142.86+25.1%-11.4%$2.12B$1.15B25.2149,703News CoverageAnalyst ForecastInsider TradeLFSTLifeStance Health Group3.1642 of 5 stars$5.41-0.6%$8.50+57.1%-10.2%$2.12B$1.25B-108.2010,218News CoverageInsider TradeCELCCelcuity1.1291 of 5 stars$51.57-0.4%$50.60-1.9%+202.1%$2.02BN/A-14.9540Short Interest ↑PGNYProgyny2.3716 of 5 stars$23.78+1.6%$24.90+4.7%+7.9%$2.01B$1.17B40.31310News CoveragePositive NewsAnalyst ForecastARDTArdent Health3.359 of 5 stars$12.64+1.2%$19.56+54.8%-25.1%$1.79B$6.20B6.9824,900PACSPACS Group2.8479 of 5 stars$11.44-0.6%$33.33+191.5%-70.9%$1.75B$3.11B0.0032,433News CoverageUpcoming EarningsNHCNational HealthCareN/A$107.76+0.2%N/A-14.4%$1.67B$1.46B13.5012,400News CoverageVRDNViridian Therapeutics1.5652 of 5 stars$18.11-2.3%$37.00+104.3%+27.8%$1.51B$300K-4.7350 Related Companies and Tools Related Companies HTFL Competitors VCYT Competitors ADUS Competitors LFST Competitors CELC Competitors PGNY Competitors ARDT Competitors PACS Competitors NHC Competitors VRDN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGT) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access